1.A qualitative study on the self-growth of caregivers of adolescents with non-suicidal self-injury
GAO Zhiyuan, YAN Fang, JI Ziyang, ZHANG Donghong
Chinese Journal of School Health 2025;46(12):1776-1781
Objective:
To explore the experience of self growth among caregivers of adolescents with non suicidal self injury (NSSI), so as to provide practical reference for improving the family support system of adolescents with NSSI.
Methods:
From August to November 2023, a purposive sampling method was used to select 21 caregivers of adolescents with NSSI who were treated in a tertiary grade A psychiatric hospital in Xinxiang City, Henan Province for semi structured in depth interviews. The Colaizzi s seven step qualitative analysis method was applied to analyze the data and extract themes related to caregiver growth
Results:
A total of 5 themes and 12 sub themes of benefit finding were extracted from caregivers of adolescents with NSSI: personal growth (increased psychological resilience, enhanced awareness of independent learning, improved self reflection ability, better understanding and acceptance of NSSI behaviors in adolescents), improvement of family relationships (improved parent-child relationship, improved relationships among family members), perceived social support (more peer support, support from close friends), improvement of caregiving ability (creating a favorable rehabilitation environment, improved caregiving skills), and changes in life and education attitudes (adopting a healthier lifestyle, reasonably adjusting expectations for children).
Conclusions
During the process of caring for adolescents with NSSI, caregivers from positive experiences in multiple aspects such as personal growth, family relationships, social support, and life education attitudes. Improving the mental health level of caregivers and optimize the family rehabilitation environment, will help reduce the occurrence of NSSI behaviors among adolescents.
2.Effects of Oral Chinese Patent Medicine Combined with Hormone Replacement Therapy in Improving Ovarian Hypofunction:A Systematic Review and Network Meta-analysis
Jing MIAO ; Zhiyuan KANG ; Haiyin HU ; Baihan NIU ; Zhaochen JI
World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(1):235-254
Objective To systematically evaluate and compare the efficacy and safety of different oral Chinese patent medicine combined with hormone replacement therapy(HRT)in the treatment of ovarian hypofunction related diseases.Methods Relevant randomized controlled studies on Chinese patent medicine combined with HRT for the treatment of premature ovarian insufficiency,diminished ovarian reserve,premature ovarian failure were systematically searched in CNKI,WanFang,VIP,SinoMed,PubMed,and WOS databases,and the network Meta-analysis was performed using R 4.1.0 software.Results Eighty-three randomized controlled studies were included,with 3819 cases in the control group and 3844 cases in the experimental group,involving a total of 14 Chinese patent medicine(Kuntai capsule,Peikun pill,Zuogui pill,Heche Dazao capsule,Zishen Yutai pill,Fuke Yangrong capsule,Liuwei Dihuang pill,Rentaipan tablet,Guishen pill,Huanshao capsule,Qilin pill,Tiaojing Cuyun pill,Fufang Ejiao plasma,and Zuogui pill+Ruogui pill).The results of network Meta-analysis showed that:①Lowering of follicle stimulating hormone:the top 3 in the ranking were Zishen Yutai pill,Liuwei Dihuang pill,Fuke Yangrong capsule combined with HRT.② Increasing antral follicle counting:the top 3 in the ranking were Zuogui pill,Fuke Yangrong capsule,Zuogui pill+Ruogui pill combined with HRT.③Elevating of anti-Müllerian tube hormones:the top 3 in the ranking were Rentaipan tablet,Liuwei Dihuang pill,Kuntai capsule combined with HRT.④ Lowering Kupperman's score:the top 1 in the ranking was Kuntai capsule+HRT.⑤ Increasing in overall efficiency:the top 3 in the ranking were Fufang Ejiao plasma+HRT,Guishen pill+HRT,Zishen Yutai pill+HRT.The adverse events of combined HRT with oral Chinese patent medicine were mainly gastrointestinal discomfort,dizziness and headache,breast distension and pain.Conclusion The combination of oral Chinese patent medicine with HRT can better improve ovarian function and alleviate perimenopausal symptoms.For patients with fertility requirements,priority should be given to Fuke Yangrong capsule or Liuwei Dihuang pill combined with HRT to improve FSH levels and increase follicular reserve.For patients with obvious perimenopausal symptoms,priority should be given to Kuntai capsule combined with HRT to alleviate the symptoms.And Fufang Ejiao plasma,Guishen pill,Zishen Yutai pill combined with HRT should be given to increase the overall effective rate of the treatment.
3.Reflections on Promoting High-quality Development of Public Hospitals Centered on People's Health
Zhe JI ; Ruijie CHANG ; Qianqian TIAN ; Yujie CUI ; Zhiyuan ZHOU ; Yuhan WU ; Shuqiang XU ; Tieshan ZHANG
Chinese Hospital Management 2025;45(10):17-20
In the context of comprehensively advancing the Healthy China initiative,the high-quality development of public hospitals must be guided by the core principle of"people's health".It provides a systematic analysis of the historical evolution of developmental paradigms in Chinese public hospitals.By integrating the current policy requirements for their high-quality development,it proposes key pathways including the innovation of development concepts,the reconstruction of hospital connotations,the extension of service management,the optimization of the system structure,and the empowerment of digital and intelligent technologies.Through empirical case studies that demonstrate the viability of these pathways,it aims to provide theoretical support and practical reference for the high-quality development of public hospitals centered on people's health.
4.Multi-parameter coronary CT angiography features based on artificial intelligence combined with clinical indicators for predicting plaque progression
Ying MENG ; Zhiyuan WANG ; Ji ZHANG ; Longshan SHEN ; Zhenhuan WANG ; Liucheng CHEN
Chinese Journal of Medical Imaging Technology 2025;41(9):1506-1511
Objective To explore the value of artificial intelligence(AI)based multi-parameter coronary CT angiography(CCTA)features combined with clinical indicators for predicting coronary plaque progression.Methods Totally 143 coronary atherosclerosis(AS)patients were retrospectively enrolled and divided into progression group(arithmetic average annual growth rate of plaque load>1%,n=73)and non-progression group(arithmetic average annual growth rate of plaque load<1%,n=70).The baseline clinical data,CT-derived fractional flow reserve(CT-FFR),perivascular fat attenuation index(FAI),and quantitative plaque features were collected and compared between groups.For variables being statistically different between groups,those had collinearity with others were excluded,and then multivariable logistic regression was used to screen independent predictors of plaque progression from the retained variables,and a combined model was constructed.Receiver operating characteristic(ROC)curve was drawn,and the area under the curve(AUC)was calculated to evaluate the predictive efficacy of this model.Results Progression group had higher proportions of hypertension and diabetes,higher apolipoprotein A1(ApoA1)and high-sensitivity C-reactive protein(hs-CRP)levels but lower high-density lipoprotein cholesterol(HDL-C)levels than non-progression group(all P<0.05).Progression group showed smaller minimum lumen area and lower CT-FFR,but greater degree of lumen stenosis,total plaque volume,plaque load,non-calcified plaque volume,lipid-rich plaque volume,fibrolipid plaque volume and FAI values than non-progression group(all P<0.05).Plaque types were different between groups(P<0.05).Diabetes,low HDL-C,small minimum lumen area and large lipid-rich plaque volume were all independent predictors of plaque progression in patients with coronary AS(all P<0.05),and the AUC of the combined model for predicting plaque progression was 0.859.Conclusion Multi-parameter CCTA features based on AI combined with clinical indicators could be used to effectively predict progression of coronary AS plaque.
5.Preliminary application of directional electrodes combined with sensible deep brain stimulation system in Parkinson′s disease patients
Ping HE ; Wei JI ; Jun LI ; Xin XU ; Along XIA ; Zhiyuan ZHENG ; Kun WU ; Zhipei LING
Chinese Journal of Neurology 2025;58(9):920-929
Objective:To preliminarily explore the application of directional electrodes with perceivable subthalamic nucleus-deep brain stimulation (STN-DBS) for Parkinson′s disease (PD).Methods:A retrospective analysis was conducted on 56 patients with primary PD who underwent STN-DBS treatment across multiple neurosurgical centers, including the Department of Neurosurgery of the First Medical Center of the Chinese People′s Liberation Army General Hospital, the Department of Neurosurgery of Hua′an Brain Hospital Affiliated to Anhui Medical University, and the Department of Neurosurgery of Hefei Second People′s Hospital, from January to December 2024. The cohort included 26 patients in the directional+perception group and 30 in the conventional group. The directional+perception group had activation contacts selected based on electrode branch contact locations and local field potential data recorded by the perceptible deep brain stimulation (DBS) system. The conventional group used contact testing to determine therapeutic contacts. Unified Parkinson′s Disease Rating Scale-Ⅲ (UPDRS-Ⅲ) assessments were performed in the medication-off state under continuous STN-DBS therapy at postoperative activation, 1, 3, and 6 months, comparing postoperative data with preoperative baseline. Initial programming outcomes were also compared between groups.Results:By combining directional electrodes with sensing capabilities, therapeutic contacts can be selected more quickly and effectively. The directional+ perception group showed significantly shorter initial programming time compared to the conventional group [(30.1±4.7) min vs (65.0±6.8) min, respectively], with a statistically significant difference ( t=-22.159, P<0.001). Compared to preoperative baseline, UPDRS-Ⅲ scores improved markedly at postoperative activation and at 1, 3, and 6 months, with improvements of 59.8%(20.6±5.2 vs 51.2±8.7), 62.1%(19.4±6.2 vs 51.2±8.7), 55.5%(22.8±7.2 vs 51.2±8.7), and 61.7%(19.6±13.9 vs 51.2±8.7), respectively. The scores of tremor showed the greatest improvement of 72.2% [2.5(0, 4.3) vs 9.0(0, 13.0)], 61.1% [3.5(0, 5.0) vs 9.0(0, 13.0)], 72.2% [2.5(0, 5.0) vs 9.0(0, 13.0)], 63.3% [0(0, 3.3) vs 9.0(0, 13.0)], respectively, followed by rigidity. Axial symptoms, postural stability, and gait improved moderately, while speech showed no significant change. Conclusions:In the treatment of PD, the combined use of directional electrodes and a perceivable DBS system allows precise selection of therapeutic contacts. This approach not only safely and effectively improves patients′ motor symptoms but also significantly reduces the time required for initial programming compared to conventional DBS systems, demonstrating clear clinical advantages.
6.Multi-parameter coronary CT angiography features based on artificial intelligence combined with clinical indicators for predicting plaque progression
Ying MENG ; Zhiyuan WANG ; Ji ZHANG ; Longshan SHEN ; Zhenhuan WANG ; Liucheng CHEN
Chinese Journal of Medical Imaging Technology 2025;41(9):1506-1511
Objective To explore the value of artificial intelligence(AI)based multi-parameter coronary CT angiography(CCTA)features combined with clinical indicators for predicting coronary plaque progression.Methods Totally 143 coronary atherosclerosis(AS)patients were retrospectively enrolled and divided into progression group(arithmetic average annual growth rate of plaque load>1%,n=73)and non-progression group(arithmetic average annual growth rate of plaque load<1%,n=70).The baseline clinical data,CT-derived fractional flow reserve(CT-FFR),perivascular fat attenuation index(FAI),and quantitative plaque features were collected and compared between groups.For variables being statistically different between groups,those had collinearity with others were excluded,and then multivariable logistic regression was used to screen independent predictors of plaque progression from the retained variables,and a combined model was constructed.Receiver operating characteristic(ROC)curve was drawn,and the area under the curve(AUC)was calculated to evaluate the predictive efficacy of this model.Results Progression group had higher proportions of hypertension and diabetes,higher apolipoprotein A1(ApoA1)and high-sensitivity C-reactive protein(hs-CRP)levels but lower high-density lipoprotein cholesterol(HDL-C)levels than non-progression group(all P<0.05).Progression group showed smaller minimum lumen area and lower CT-FFR,but greater degree of lumen stenosis,total plaque volume,plaque load,non-calcified plaque volume,lipid-rich plaque volume,fibrolipid plaque volume and FAI values than non-progression group(all P<0.05).Plaque types were different between groups(P<0.05).Diabetes,low HDL-C,small minimum lumen area and large lipid-rich plaque volume were all independent predictors of plaque progression in patients with coronary AS(all P<0.05),and the AUC of the combined model for predicting plaque progression was 0.859.Conclusion Multi-parameter CCTA features based on AI combined with clinical indicators could be used to effectively predict progression of coronary AS plaque.
7.Effects of Oral Chinese Patent Medicine Combined with Hormone Replacement Therapy in Improving Ovarian Hypofunction:A Systematic Review and Network Meta-analysis
Jing MIAO ; Zhiyuan KANG ; Haiyin HU ; Baihan NIU ; Zhaochen JI
World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(1):235-254
Objective To systematically evaluate and compare the efficacy and safety of different oral Chinese patent medicine combined with hormone replacement therapy(HRT)in the treatment of ovarian hypofunction related diseases.Methods Relevant randomized controlled studies on Chinese patent medicine combined with HRT for the treatment of premature ovarian insufficiency,diminished ovarian reserve,premature ovarian failure were systematically searched in CNKI,WanFang,VIP,SinoMed,PubMed,and WOS databases,and the network Meta-analysis was performed using R 4.1.0 software.Results Eighty-three randomized controlled studies were included,with 3819 cases in the control group and 3844 cases in the experimental group,involving a total of 14 Chinese patent medicine(Kuntai capsule,Peikun pill,Zuogui pill,Heche Dazao capsule,Zishen Yutai pill,Fuke Yangrong capsule,Liuwei Dihuang pill,Rentaipan tablet,Guishen pill,Huanshao capsule,Qilin pill,Tiaojing Cuyun pill,Fufang Ejiao plasma,and Zuogui pill+Ruogui pill).The results of network Meta-analysis showed that:①Lowering of follicle stimulating hormone:the top 3 in the ranking were Zishen Yutai pill,Liuwei Dihuang pill,Fuke Yangrong capsule combined with HRT.② Increasing antral follicle counting:the top 3 in the ranking were Zuogui pill,Fuke Yangrong capsule,Zuogui pill+Ruogui pill combined with HRT.③Elevating of anti-Müllerian tube hormones:the top 3 in the ranking were Rentaipan tablet,Liuwei Dihuang pill,Kuntai capsule combined with HRT.④ Lowering Kupperman's score:the top 1 in the ranking was Kuntai capsule+HRT.⑤ Increasing in overall efficiency:the top 3 in the ranking were Fufang Ejiao plasma+HRT,Guishen pill+HRT,Zishen Yutai pill+HRT.The adverse events of combined HRT with oral Chinese patent medicine were mainly gastrointestinal discomfort,dizziness and headache,breast distension and pain.Conclusion The combination of oral Chinese patent medicine with HRT can better improve ovarian function and alleviate perimenopausal symptoms.For patients with fertility requirements,priority should be given to Fuke Yangrong capsule or Liuwei Dihuang pill combined with HRT to improve FSH levels and increase follicular reserve.For patients with obvious perimenopausal symptoms,priority should be given to Kuntai capsule combined with HRT to alleviate the symptoms.And Fufang Ejiao plasma,Guishen pill,Zishen Yutai pill combined with HRT should be given to increase the overall effective rate of the treatment.
8.Reflections on Promoting High-quality Development of Public Hospitals Centered on People's Health
Zhe JI ; Ruijie CHANG ; Qianqian TIAN ; Yujie CUI ; Zhiyuan ZHOU ; Yuhan WU ; Shuqiang XU ; Tieshan ZHANG
Chinese Hospital Management 2025;45(10):17-20
In the context of comprehensively advancing the Healthy China initiative,the high-quality development of public hospitals must be guided by the core principle of"people's health".It provides a systematic analysis of the historical evolution of developmental paradigms in Chinese public hospitals.By integrating the current policy requirements for their high-quality development,it proposes key pathways including the innovation of development concepts,the reconstruction of hospital connotations,the extension of service management,the optimization of the system structure,and the empowerment of digital and intelligent technologies.Through empirical case studies that demonstrate the viability of these pathways,it aims to provide theoretical support and practical reference for the high-quality development of public hospitals centered on people's health.
9.Preliminary application of directional electrodes combined with sensible deep brain stimulation system in Parkinson′s disease patients
Ping HE ; Wei JI ; Jun LI ; Xin XU ; Along XIA ; Zhiyuan ZHENG ; Kun WU ; Zhipei LING
Chinese Journal of Neurology 2025;58(9):920-929
Objective:To preliminarily explore the application of directional electrodes with perceivable subthalamic nucleus-deep brain stimulation (STN-DBS) for Parkinson′s disease (PD).Methods:A retrospective analysis was conducted on 56 patients with primary PD who underwent STN-DBS treatment across multiple neurosurgical centers, including the Department of Neurosurgery of the First Medical Center of the Chinese People′s Liberation Army General Hospital, the Department of Neurosurgery of Hua′an Brain Hospital Affiliated to Anhui Medical University, and the Department of Neurosurgery of Hefei Second People′s Hospital, from January to December 2024. The cohort included 26 patients in the directional+perception group and 30 in the conventional group. The directional+perception group had activation contacts selected based on electrode branch contact locations and local field potential data recorded by the perceptible deep brain stimulation (DBS) system. The conventional group used contact testing to determine therapeutic contacts. Unified Parkinson′s Disease Rating Scale-Ⅲ (UPDRS-Ⅲ) assessments were performed in the medication-off state under continuous STN-DBS therapy at postoperative activation, 1, 3, and 6 months, comparing postoperative data with preoperative baseline. Initial programming outcomes were also compared between groups.Results:By combining directional electrodes with sensing capabilities, therapeutic contacts can be selected more quickly and effectively. The directional+ perception group showed significantly shorter initial programming time compared to the conventional group [(30.1±4.7) min vs (65.0±6.8) min, respectively], with a statistically significant difference ( t=-22.159, P<0.001). Compared to preoperative baseline, UPDRS-Ⅲ scores improved markedly at postoperative activation and at 1, 3, and 6 months, with improvements of 59.8%(20.6±5.2 vs 51.2±8.7), 62.1%(19.4±6.2 vs 51.2±8.7), 55.5%(22.8±7.2 vs 51.2±8.7), and 61.7%(19.6±13.9 vs 51.2±8.7), respectively. The scores of tremor showed the greatest improvement of 72.2% [2.5(0, 4.3) vs 9.0(0, 13.0)], 61.1% [3.5(0, 5.0) vs 9.0(0, 13.0)], 72.2% [2.5(0, 5.0) vs 9.0(0, 13.0)], 63.3% [0(0, 3.3) vs 9.0(0, 13.0)], respectively, followed by rigidity. Axial symptoms, postural stability, and gait improved moderately, while speech showed no significant change. Conclusions:In the treatment of PD, the combined use of directional electrodes and a perceivable DBS system allows precise selection of therapeutic contacts. This approach not only safely and effectively improves patients′ motor symptoms but also significantly reduces the time required for initial programming compared to conventional DBS systems, demonstrating clear clinical advantages.
10.Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma
Liu ZHEQI ; Zhang ZHEN ; Zhang YU ; Zhou WENKAI ; Zhang XU ; Peng CANBANG ; Ji TONG ; Zou XIN ; Zhang ZHIYUAN ; Ren ZHENHU
International Journal of Oral Science 2024;16(1):110-121
Tumor progression is closely related to tumor tissue metabolism and reshaping of the microenvironment.Oral squamous cell carcinoma(OSCC),a representative hypoxic tumor,has a heterogeneous internal metabolic environment.To clarify the relationship between different metabolic regions and the tumor immune microenvironment(TME)in OSCC,Single cell(SC)and spatial transcriptomics(ST)sequencing of OSCC tissues were performed.The proportion of TME in the ST data was obtained through SPOTlight deconvolution using SC and GSE103322 data.The metabolic activity of each spot was calculated using scMetabolism,and k-means clustering was used to classify all spots into hyper-,normal-,or hypometabolic regions.CD4T cell infiltration and TGF-β expression is higher in the hypermetabolic regions than in the others.Through CellPhoneDB and NicheNet cell-cell communication analysis,it was found that in the hypermetabolic region,fibroblasts can utilize the lactate produced by glycolysis of epithelial cells to transform into inflammatory cancer-associated fibroblasts(iCAFs),and the increased expression of HIF1A in iCAFs promotes the transcriptional expression of CXCL12.The secretion of CXCL12 recruits regulatory T cells(Tregs),leading to Treg infiltration and increased TGF-β secretion in the microenvironment and promotes the formation of a tumor immunosuppressive microenvironment.This study delineates the coordinate work axis of epithelial cells-iCAFs-Tregs in OSCC using SC,ST and TCGA bulk data,and highlights potential targets for therapy.


Result Analysis
Print
Save
E-mail